Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|November 12, 2010
A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancerAthanasios Kotsakis, Sophia Agelaki, Nikolaos Vardakis, et al.Lung Cancer (Amsterdam, Netherlands)|April 20, 2007
Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcomeAnastassios V Koutsopoulos, Dimitris Mavroudis, Konstantina I Dambaki, et al.Cancer Research and Treatment|March 28, 2019
Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon CancerMaria Sfakianaki, Chara Papadaki, Maria Tzardi, et al.Nutrition and Cancer|November 22, 2011
Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosisIoannis Gioulbasanis, Anna Patrikidou, Kyriaki Kitikidou, et al.Clinical Lung Cancer|December 16, 2005
Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research GroupMichail Ignatiadis, Dimitris Mavroudis, Marinos Veslemes, et al.Plos One|December 25, 2013
BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcomeZacharenia Saridaki, Maria Tzardi, Maria Sfakianaki, et al.Anticancer Research|April 12, 2003
A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancerCharalambos Kouroussis, Sophia Agelaki, Dimitris Mavroudis, et al.Oncology|November 14, 2007
A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumorsZacharenia Saridaki, Vasiliki Bozionelou, Nikolaos Kentepozidis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancerNikolaos Xenidis, Michail Ignatiadis, Stella Apostolaki, et al.Plos One|February 2, 2011
Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patientsZacharenia Saridaki, Maria Tzardi, Chara Papadaki, et al.Pageof 12